References
- Abboud EC, Legare TB, Settle JC, et al. Do silver-based wound dressings reduce pain? A prospective study and review of the literature. Burns. 2014;40(suppl 1): S40–S47.
- Benbow M. Best practice in wound assessment. Nurs Stand. 2016;30(27):40–47.
- Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li YF. Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs. 2012;68(6):1312–1321.
- Adderley U.J., Holt I.G. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014;(5):CD003948.
- Alexander S. Malignant fungating wounds: key symptoms and psychosocial issues. J Wound Care. 2009;18: 325–329.
- Fromantin I, Watson S, Baffie A, et al. A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. Ostomy Wound Manage. 2014;60(6):38–48.
- Samala RV, Davis MP. Comprehensive wound malodor management: win the RACE. Cleve Clin J Med. 2015;82(8):535–543.
- Langemo DK, Anderson J, Hanson D, Hunter S, Thompson P. Managing fungating wounds. Adv Skin Wound Care. 2007;20(6):312–314.
- Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009;13(4):295–298.
- Thomas S, Fisher B, Fram PJ, Waring MJ. Odour-absorbing dressings. J Wound Care. 1998;7(5):246–250.
- Ramasubbu DA, Smith V, Hayden F, Cronin P. Systemic antibiotics for treating malignant wounds. Cochrane Database Syst Rev. 2017;8:CD011609.
- Samala RV, Davis MP. Comprehensive wound malodor management: win the RACE. Cleve Clin J Med. 2015;82(8):535–543.
- Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. Eur J Cancer. 1992;28a(4–5):888–889.
- Watanabe K, Shimo A, Tsugawa K, et al. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013). Support Care Cancer. 2016;24(6):2583–2590.
- Kuge S, Tokuda Y, Ohta M, et al. Use of metronidazole gel to control malodor in advanced and recurrent breast cancer. Jpn J Clin Oncol. 1996;26(4):207–210.
- Adderley UJ, Holt IG. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014(5):CD003948.
- Akhmetova A, Saliev T, Allan IU, Illsley MJ, Nurgozhin T, Mikhalovsky S. A comprehensive review of topical odor-controlling treatment options for chronic wounds. J Wound Ostomy Continence Nurs. 2016;43(6):598–609.
- Coombs TJ. Product profile: more than a wound dressing. Health Soc Serv J. 1981;91(4768):1268–1269.
- Graham C. The role of silver in wound healing. Br J Nurs. 2005;14(19): S22, S24, S26.
- Kalemikerakis J, Vardaki Z, Fouka G, et al. Comparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds. J Buon. 2012;17(3):560–564.